About Si-Bone
Si-Bone is a company based in San Jose (United States) founded in 2008. Si-Bone has raised $102.52 million across 7 funding rounds from investors including SVB, Orbimed and Oxford Finance. The company has 344 employees as of December 31, 2023. Si-Bone offers products and services including iFuse Implant System, iFuse 3D, and iFuse TORQ. Si-Bone operates in a competitive market with competitors including Nevro, ATEC Spine, Vertos Medical, Paradigm Spine and Relievant Medsystems, among others.
- Headquarter San Jose, United States
- Employees 344 as on 31 Dec, 2023
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Si-Bone, Inc.
-
Annual Revenue
$167.18 M (USD)28as on Dec 31, 2024
-
Net Profit
$1.9 M (USD)104as on Dec 31, 2024
-
EBITDA
-$35.25 M (USD)25as on Dec 31, 2024
-
Total Equity Funding
$102.52 M (USD)
in 7 rounds
-
Latest Funding Round
$20 M (USD), Series D
Jun 17, 2016
-
Investors
SVB
& 7 more
-
Employee Count
344
as on Dec 31, 2023
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Si-Bone
Si-Bone is a publicly listed company on the NASDAQ with ticker symbol SIBN in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Si-Bone
Si-Bone offers a comprehensive portfolio of products and services, including iFuse Implant System, iFuse 3D, and iFuse TORQ.
Device for stabilizing and fusing the sacroiliac joint
Advanced implant for SI joint dysfunction treatment
Implant system for pelvic trauma and fixation
People of Si-Bone
Unlock access to complete
Unlock access to complete
Funding Insights of Si-Bone
Si-Bone has successfully raised a total of $102.52M across 7 strategic funding rounds. The most recent funding activity was a Series D round of $20 million completed in June 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 7
- Last Round Series D — $20.0M
-
First Round
First Round
(26 Mar 2009)
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2016 | Amount | Series D - Si-Bone | Valuation | Arboretum Ventures |
|
| Nov, 2015 | Amount | Debt – Conventional - Si-Bone | Valuation |
investors |
|
| May, 2015 | Amount | Series D - Si-Bone | Valuation |
investors |
Investors in Si-Bone
Si-Bone has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include SVB, Orbimed and Oxford Finance.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Healthcare venture capital investments are made by Arboretum Ventures.
|
Founded Year | Domain | Location | |
|
Venture debt firm focused on the life sciences sector
|
Founded Year | Domain | Location | |
|
Growth-stage tech investments are made in North America, Europe, Israel.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Si-Bone
Financial Statements - Si-Bone
Si-Bone Comparisons
Competitors of Si-Bone
Si-Bone operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Nevro, ATEC Spine, Vertos Medical, Paradigm Spine and Relievant Medsystems, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of high-frequency spinal cord stimulation implants
|
|
| domain | founded_year | HQ Location |
Treatment solutions for spine disorders are developed.
|
|
| domain | founded_year | HQ Location |
Minimally invasive treatments for lumbar spinal stenosis are developed.
|
|
| domain | founded_year | HQ Location |
Stabilization devices for healthcare are manufactured by the company.
|
|
| domain | founded_year | HQ Location |
Developer of medical devices for patients suffering from chronic vertebrogenic low back pain
|
Frequently Asked Questions about Si-Bone
Si-Bone was founded in 2008 and raised its 1st funding round 1 year after it was founded.
Si-Bone is headquartered in San Jose, United States. It is registered at San Jose, California, United States.
Si-Bone is a funded company, having raised a total of $102.52M across 7 funding rounds to date. The company's 1st funding round was a Series D of $21M, raised on Mar 26, 2009.
As of Dec 31, 2023, the latest employee count at Si-Bone is 344.
Annual revenue of Si-Bone is $167.18M as on Dec 31, 2024.
SI-BONE was founded in 2008 in San Jose, United States, and is engaged in the medical device sector for orthopedic treatments. The iFuse Implant System is provided as a titanium-based solution for minimally invasive sacroiliac joint fusion surgeries. A directory of physicians qualified to perform these procedures is maintained. Operations center on addressing SI joint disorders through innovative fixation technologies.
Si-Bone's top competitors include Nevro, Paradigm Spine and ATEC Spine.
Si-Bone offers iFuse Implant System, iFuse 3D, and iFuse TORQ.
Yes, Si-Bone is publicly traded on NASDAQ under the ticker symbol SIBN.
Si-Bone has 8 investors. Key investors include SVB, Orbimed, Oxford Finance, Arboretum Ventures, and Redline Capital Management.
The ticker symbol of Si-Bone is SIBN on NASDAQ.